CoChat

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index; 2 of the 32 sources its claims cite were checked for support.

Investigating the Effectiveness, Acceptability and Impact on Healthcare Usage of Providing a Cognitive-Behavioural Based Psychological Therapy Service for Patients with Primary Antibody Deficiency

Campbell, Mari, Clarke, Alex, Symes, Andrew, Workman, Sarita, Stauss, Hans, Webster, A. David · 2018 · Journal of Clinical Immunology

Abstract

Purpose: Patients with primary antibody deficiency report poorer quality of life and higher rates of anxiety and depression than the general population. Cognitive-behavioral therapy has been shown to be a valuable treatment for patients with other long-term physical health conditions, improving well-being and enabling them to manage their symptoms more effectively. The aim of this project was to establish the feasibility and effectiveness of providing cognitive-behavioral based therapy to patients with primary antibody deficiency. Methods: Forty-four patients completed a course of psychological therapy. Participants completed a series of self-report measures examining psychological and physical health, and service usage, prior to starting treatment and following their final session. They also provided feedback on their experience of treatment. Results: Patients showed improvements in anxiety, depression, insomnia and fatigue. There was a high level of acceptability of the service and the potential for long-term cost savings to the NHS. Conclusion: Psychological therapy based on the cognitive-behavioral model of treatment appears to be a valuable treatment for patients with primary antibody deficiency and comorbid mental health difficulties. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.

Overview

CoChat Summary

## TL;DR

This case series assessed a cognitive-behavioural based psychological therapy service for patients with primary antibody deficiency (PAD) and found improvements in several mental health and fatigue outcomes after treatment. The service was also reported as highly acceptable, with signals of possible changes in healthcare use and potential NHS cost savings, though the authors note important design limitations.

## Key findings

  • 44 patients completed a course of psychological therapy in the abstract, while the Results section reports 55 patients consented and 41 completed a full course of treatment, with 5 partial completers and 1 patient remaining in treatment excluded from further analysis.
  • Among treatment completers, there were significant improvements in HADS anxiety (9.1 to 7.2, p = .002), HADS depression (6.5 to 4.6, p = .003), FACIT fatigue (24.8 to 29.2, p = .002), PIQoLI depression (4.7 to 3.4, p = .004), PIQoLI fatigue (9.5 to 7.2, p = .001), and PIQoLI insomnia (13.1 to 9.3, p = .001).
  • Hours outside the home per week increased from 25.0 to 35.3 (Z = -2.910, p = .004), while days off work due to ill health changed from 0.0 to 1.0 (p = .019, n.s. as labeled in the table) and days unable to complete household tasks changed from 2.5 to 2.0 (p = .303, n.s.).
  • Acceptability was high: FACIT Treatment Satisfaction = 91.7% (SD 15.6; N = 40) and FACIT Treatment Recommendation = 98.1% (SD 8.9; N = 39); 39/40 would recommend the treatment and 37 would choose it again. The paper also reports a 12% total attrition rate and 10.2% within-treatment attrition, compared with population averages of 36% and 26.2% respectively.

## Methods

  • Design: A case series of psychological therapy for patients with PAD, using pre-treatment and post-treatment self-report measures.
  • Sample/data: Patients attending the Royal Free Hospital Clinical Immunology Department who were prescribed Immunoglobulin Replacement Therapy and identified by screening as experiencing anxiety, depression, insomnia, or fatigue; 55 consented and attended assessment.
  • Analysis: Change from baseline to end of treatment was tested with paired t-tests for parametric data and Wilcoxon signed-rank tests for non-parametric data, using alpha = 0.004; acceptability was assessed with drop-out rates and FACIT-TS-G, and healthcare usage from self-reported counts of GP/hospital/emergency contacts and admissions.

## Limitations

  • The authors explicitly note the small sample size, high level of analysis, heterogeneity of the population, and that participants were not randomised, so a formal intention-to-treat analysis was not undertaken.
  • The paper states that a control group is needed to ensure improvement can be attributed to CBT rather than non-specific treatment benefits, and that longer-term follow-up is needed to know whether effects persist.
  • Evident from the text: the study was conducted in a single specialist service with one Clinical Psychologist, which the authors say limits generalisability to wider PAD/immune deficiency populations.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s10875-018-0481-3

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

2 Valid · 0 Not valid · 18 Not checked · 30 Own results and interpretations

13 more claims

Create a free account to see all 50 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 19
  • It may state two separate claims as one. 19
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 16 references

Research works printed but not linked: 2

  1. Department of Health. Long-term conditions positive practice guide. London: Department of Health; 2008.
  2. Department of Health. No health without mental health: a cross-government mental health outcomes strategy for people of all ages. London: Department of Health; 2011.

Cited by

See all 5

Metadata

Authors
Campbell, M., Clarke, A., Symes, A., Workman, S., Stauss, H., & Webster, A. D.
Affiliations
  • Royal Free London NHS Foundation Trust (GB)
  • University of the West of England (GB)
Corresponding author
Campbell, Mari
Venue
Journal of Clinical Immunology
Published
2018-02
Volume
38
Issue
2
Pages
214-220
ISSN
  • 0271-9142 (ISSN-L)
  • 1573-2592
OpenAlex
W2790896363
Cited by
5
References
16
Citations by year
2026: 1 · 2025: 1 · 2022: 1 · 2020: 1 · 2019: 1
FWCI
0.21
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Clinical Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
CSL Behring
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Assessments
Keywords
primary antibody deficiency, cognitive behavioral therapy, psychotherapy, anxiety, depression, insomnia, fatigue, treatment acceptability, quality of life, cost reduction, feasibility, long-term physical health conditions
MeSH terms
Adult, Agammaglobulinemia, Anxiety, Mental Disorders, Cost-Benefit Analysis, Depression, Female, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Quality of Life, Cognitive Behavioral Therapy, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Investigating the Effectiveness, Acceptability and Impact on Healthcare Usage of Providing a Cognitive-Behavioural Based Psychological Therapy Service for Patients with Primary Antibody Deficiency. https://app.cochat.ai/papers/10.1007/s10875-018-0481-3
The paper
Campbell, M., Clarke, A., Symes, A., Workman, S., Stauss, H., & Webster, A. D. (2018). Investigating the Effectiveness, Acceptability and Impact on Healthcare Usage of Providing a Cognitive-Behavioural Based Psychological Therapy Service for Patients with Primary Antibody Deficiency. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-018-0481-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.